| Sinonasal Neoplasm studied in …STUDIED_INderived78 of 78show fewer |
|---|
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Nasal Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Nasal Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493425Phase 2 · active not recruiting Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281417Phase 2 · recruiting Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Sinonasal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03803774Phase 1 · active not recruiting Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567422Phase 1 · active not recruiting Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Nasal Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522879Phase 2 · recruiting A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707473Phase 2 · terminated Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Nasal Cavity Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645846Phase 2 · not yet recruiting Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Nasal Cavity Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652489recruiting Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07320508Phase 2 · recruiting Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563088not yet recruiting SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209189Phase 2 · recruiting Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05925491Phase 2 · recruiting Pembrolizumab in Locally Advanced Sinonasal Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870762Phase 2 · recruiting Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Maxillary Sinus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07512466NA · not yet recruiting Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04755855recruiting Prospective Sinonasal Cancer Multi-institution Study · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483374recruiting The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370276Phase 1/Phase 2 · completed Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868433Phase 1 · recruiting TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07063212Phase 2 · recruiting A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Nasal Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082534Phase 2 · completed Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468218Phase 2 · active not recruiting Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381183Phase 1 · completed IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979000completed HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012098Phase 2 · completed Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Nasal Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879484Phase 1/Phase 2 · withdrawn Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Sinonasal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04330781Phase 2 · completed Radiotherapy of Head and Neck Cancer Using an Intraoral Stent · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Sinonasal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788264NA · completed Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Maxillary Sinus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03274414Phase 2 · completed A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06865313completed Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Maxillary Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162873Phase 2 · terminated Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538510Phase 1/Phase 2 · completed Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Paranasal Sinus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422536Phase 2 · completed Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879654Phase 2 · unknown Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090214NA · unknown Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE) · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Ethmoid Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05992610NA · unknown Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05151588Phase 2 · not yet recruiting Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032250NA · completed Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04374448NA · unknown Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery · condition mapped PROBABILISTIC · 78 trials mapped (37 active) | — | — | Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05614375unknown Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Nasal Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05298969NA · unknown Temporalis Myofascial Flap Effectiveness · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Maxillary Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114707Phase 2 · unknown Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Nasal Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096808Phase 2 · completed Adaptive Radiotherapy for Head and Neck Cancer · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942380NA · unknown Cell-free Tumor DNA in Head and Neck Cancer Patients · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Sinonasal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009446early Phase 1 · unknown Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469429Phase 1/Phase 2 · completed Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03049358NA · terminated Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Malignant Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02388932NA · terminated Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117572Phase 3 · completed Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) · condition mapped ALIAS · 78 trials mapped (37 active) | — | — | Malignant Nasal Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462735Phase 2 · completed Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196168Phase 2 · terminated Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267240Phase 2 · terminated Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00970502Phase 1/Phase 2 · completed Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 78 trials mapped (37 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00347256NA · withdrawn Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer · condition mapped ONTOLOGY_EXACT · 78 trials mapped (37 active) | — | — | Paranasal Sinus Neoplasm | 1 | Observed | clinicaltrials | graph → |